NZX50 slides to nine-month low

NZX50 slides to nine-month low
A new drug has weighed on Fisher and Paykel's shares. (Image: Getty)
Graham Skellern
A weight-reducing drug is causing trouble for Fisher and Paykel Healthcare as the New Zealand sharemarket chalked up its sixth successive fall.The S&P/NZX 50 Index was on a downward slide all day and closed at 11,344.11, down 82.73 points or 0.72% – its lowest level for nine months.The index has now fallen 1.8% for the year and was at 11308.31 points on November 28.There were 42 gainers and 84 decliners on the main board, with 28.19 million shares worth $102.5m changing hands.Under pressureMarket heavyweight Fisher and Paykel Healthca...

More Markets

These shares are 'priced for awful' and big investors are buying
Markets

These shares are 'priced for awful' and big investors are buying

Kathmandu, SkyCity and Fletcher shares are under pressure. Some are taking the plunge.

NZ sharemarket drifts lower
Markets Market close

NZ sharemarket drifts lower

The S&P/NZX 50 Index closed at 11,776.73, easing 12.65 points or 0.11%.

Graham Skellern 02 Jul 2024
Aust shares dip again as traders digest RBA minutes
Markets

Aust shares dip again as traders digest RBA minutes

The ASX200 was down 0.2% at midday, on track for its second day of modest losses.

AAP 02 Jul 2024
Santana Minerals wants to list on NZX
Markets

Santana Minerals wants to list on NZX

The ASX company has applied for a secondary listing on the NZX main board.

Staff reporters 02 Jul 2024